Frankfurt
21.11.24
09:06 Uhr
0,173 Euro
-0,004
-2,26 %
-2,26 %
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | SkinBioTherapeutics - Finalisation of commercial agreement with Croda | 2 | RNS | ||
| 23.10. | IN BRIEF: SkinBioTherapeutics boosts financial 2025 turnover forecast | 2 | Alliance News | ||
| 23.10. | SkinBioTherapeutics - Integration update and share price movement | - | RNS | ||
| 16.10. | SkinBioTherapeutics - Issue of Equity and Total Voting Rights | 1 | RNS | ||
| SKINBIOTHERAPEUTICS Aktie jetzt für 0€ handeln | |||||
| 11.10. | AIM WINNERS & LOSERS: SkinBioTherapeutics and Oxford Metrics make buys | 3 | Alliance News | ||
| 11.10. | SkinBioTherapeutics shares jump on acquisition of topical cream maker | 5 | Sharecast | ||
| 11.10. | SkinBioTherapeutics - Acquisition and Financial Update | 1 | RNS | ||
| 04.10. | SkinBioTherapeutics - Notice of Investor Meet Company Presentation | 1 | RNS | ||
| 19.09. | SkinBioTherapeutics reports positive results from testing with Croda | 4 | Sharecast | ||
| 19.09. | AIM WINNERS & LOSERS: SkinBioTherapeutics gets Croda positive feedback | 4 | Alliance News | ||
| 19.09. | SkinBioTherapeutics - Final testing of SkinBiotix by Croda completed | 2 | RNS | ||
| 02.08. | SkinBioTherapeutics secures £1.56m from new investors | 2 | Sharecast | ||
| 02.08. | SkinBioTherapeutics lands GBP1.6 million investment to support growth | 1 | Alliance News | ||
| 02.08. | SkinBioTherapeutics - Investment of £1.56m from new investors | 1 | RNS | ||
| 29.07. | SkinBio says trading "better than expected" as revenue grows | 1 | Alliance News | ||
| 29.07. | SkinBioTherapeutics reports better-than-expected full-year trading | 1 | Sharecast | ||
| 29.07. | SkinBioTherapeutics - Appointment of Senior Croda VP as Board Advisor | 1 | RNS | ||
| 29.07. | SkinBioTherapeutics - Full year trading update | 1 | RNS | ||
| 23.07. | SkinBio announces closure of its convertible bond facility | 1 | Alliance News | ||
| 23.07. | SkinBioTherapeutics - Closure of Convertible Bond Facility | 1 | RNS |
Seite:
1 2 Weiter >>
25 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| DESTINY PHARMA | 0,048 | 0,00 % | JP Jenkins Ltd: Destiny Pharma to Deliver Presentation at the European Society of Clinical Microbiology and Infectious Disease conference on XF-73 Nasal Gel and the Use of Post-Operative Antibiotics in Cardio-vascula | JP Jenkins Ltd
Destiny Pharma to Deliver Presentation at the European Society of Clinical Microbiology and Infectious Disease conference on XF-73 Nasal Gel and the Use of Post-Operative... ► Artikel lesen | |
| ADMA BIOLOGICS | 21,370 | 0,00 % | Adma Biologics Aktie: Erholung nach starkem Kursrückgang | ||
| RECURSION PHARMACEUTICALS | 6,040 | 0,00 % | Recursion Pharmaceuticals, Inc.: Recursion and Exscientia, two leaders in the AI drug discovery space, have officially combined to advance the industrialization of drug discovery | Recursion unveils post-combination technology-enabled portfolio with more than 10 clinical and preclinical programs, 10 advanced discovery programs, and more than 10 partnered programsPlatform will... ► Artikel lesen | |
| EVOTEC | 9,735 | -1,72 % | KURSEXPLOSION bei Biotech-Aktie! BioNTech, Evotec, Nyxoah | Geht es bei Evotec jetzt doch ganz schnell? Ein Finanzinvestor positioniert sich jedenfalls für eine Übernahme und die Aktie schoss zuletzt kräftig nach oben. Ist damit die Enttäuschung über die Quartalszahlen... ► Artikel lesen | |
| QIAGEN | 40,105 | +3,26 % | Neue 6,00% Aktienanleihe mit Barriere auf QIAGEN in Zeichnung | München (www.anleihencheck.de) - Die Experten vom Zertifikate-Team der Bank Vontobel Europe AG bieten eine neue Aktienanleihe (ISIN DE000VC7RDU1/ WKN VC7RDU) mit Barriere auf die Aktie von QIAGEN (ISIN... ► Artikel lesen | |
| QUANTUM-SI | 1,400 | 0,00 % | Quantum-Si Inc - 8-K, Current Report | ||
| 89BIO | 7,980 | 0,00 % | 89bio, Inc.: 89bio Presents New Analyses Evaluating Pegozafermin and Potential Benefit of Non-Invasive Tests from the ENLIVEN Phase 2b Trial in MASH Patients at AASLD The Liver Meeting 2024 | SAN FRANCISCO, Nov. 15, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for... ► Artikel lesen | |
| LONGBOARD PHARMACEUTICALS | 59,76 | 0,00 % | Longboard Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Corporate Updates | LA JOLLA, Calif.--(BUSINESS WIRE)--Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological... ► Artikel lesen | |
| RELAY THERAPEUTICS | 4,660 | 0,00 % | Aktie von Relay Therapeutics erreicht 52-Wochen-Tief bei 5,59 US-Dollar | ||
| STRUCTURE THERAPEUTICS | 32,710 | 0,00 % | Structure Therapeutics reports Q3 results | ||
| SPRINGWORKS THERAPEUTICS | 37,440 | 0,00 % | SpringWorks started at outperform by Evercore ahead of FDA decision | ||
| 4D MOLECULAR THERAPEUTICS | 8,410 | 0,00 % | Analyst Expectations For 4D Molecular Therapeutics' Future | ||
| DYNE THERAPEUTICS | 30,000 | 0,00 % | Wissenschaftliche Leiterin von Dyne Therapeutics verkauft Aktien im Wert von 80.539 US-Dollar | ||
| CULLINAN THERAPEUTICS | 12,580 | 0,00 % | Cullinan Therapeutics, Inc.: Cullinan Therapeutics Announces Preclinical Data for CLN-978, a CD19-directed T Cell Engager, to be Presented at ACR Convergence 2024 | Cullinan will present new in vitro preclinical data that provide further strong rationale for broad clinical development of CLN-978 in autoimmune diseases Cullinan will share details of global Phase... ► Artikel lesen | |
| VIR BIOTECHNOLOGY | 6,740 | 0,00 % | Needham & Company LLC Reaffirms Buy Rating for Vir Biotechnology (NASDAQ:VIR) |
Das Unternehmen SKINBIOTHERAPEUTICS PLC kann der Branche Biotechnologie zugeordnet werden. Der aktuelle Kurs liegt bei 0,173 Euro und damit -2,26 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SKINBIOTHERAPEUTICS PLC finden Sie auf Wallstreet Online.
